Safety, Pharmacokinetics and Pharmocodynamics of Recombinant Human Porphobilinogen Deaminase in Healthy Subjects and Asymptomatic Carriers of the Acute Intermittent Porphyria Gene Who Have Increased Porphyrin Precursor Excretion

Author： Sardh Eliane  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.4, 2007-01, pp. : 335-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics Meta-Analysis of Recombinant Human Erythropoietin in Healthy Subjects

By Olsson-Gisleskog Per  

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 159-173

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Subcutaneous Recombinant Methionyl Human Leptin Administration in Healthy Subjects in the Fed and Fasting States: Regulation by Gender and Adiposity

By Chan Jean L.  

Clinical Pharmacokinetics, Vol. 47, Iss. 11, 2008-01 ,pp. : 753-764

Adis International

Access to resources Recommend Favorite

Safety, bioavailability, and pharmacokinetics of VGX‐1027—A novel oral anti‐inflammatory drug in healthy human subjects

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 91-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

By Noveck Robert J.  

Clinical Pharmacokinetics, Vol. 46, Iss. 6, 2007-01 ,pp. : 525-534

Adis International

Access to resources Recommend Favorite

The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects

By Kadokura Takeshi   Adel Martin   Krauwinkel Walter   Takeshige Tetsuo   Nishida Akito  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 605-609

Springer Publishing Company

Access to resources Recommend Favorite